KLRD1 and cancer: In addition to cytokines and adjuvants, the use of soluble NK cell receptors and antibodies targeting activating or inhibitory NK cell receptors could be utilized to modulate NK cell function and influence the adaptive immune response during infection, autoimmunity and cancer (Figure 1C).